CHD1 and adenocarcinoma: Although further confirmatory studies are required, we present preliminary data that loss of CHD1 appears to sensitize toward B7H3-PBD-ADCs killing, as observed for the SLFN11NEG/RB1WT adenocarcinoma model, LuCaP 141.